Various adjunctive tests are commercially available for primary, secondary, and tertiary oral health clinicians who wish to assess oral cavity lesions beyond the conventional visual and tactile ...

Recent research suggests that blood tests may show markers of oral cancer. But a blood test isn’t enough to confirm an oral cancer diagnosis. A biopsy is the only way to confirm it. Blood tests for ...

OrisDX has developed a novel saliva-based molecular test to detect and diagnose oral cancer earlier—improving patient outcomes and saving lives. Currently, no oral cancer salivary diagnostics are ...

Benign tumors of the oral cavity are atypical formations of noncancerous cells that grow in the mouth. They can look like sores or lumps, and they typically develop slowly. Benign oral tumors are ...

Oral cancer screening is now integral to a patient's routine follow-up, as well as new patient evaluations. Spurred by the rise in oral cancer cases, this examination must be performed more frequently ...

A University of Chicago spinout has raised $4 million in seed funding to develop a unique, saliva-based test for oral cancers. OrisDX's funding was led by Revere Partners and strategic investment from ...

Children can get oral cancer, but it is rare. Most growths in the mouth are not cancerous. However, it is possible, so it is important to know the potential signs. Regular dental checkups can help ...

Spit could be the key to detecting cancer, thanks to a new collaboration between Salignostics, a Jerusalem-based startup developing rapid saliva diagnostic tests, and the ARC Innovation Center at ...

Cavities are one of the most common forms of tooth decay among children in the United States. They affect roughly 20 percent of children between the ages of 5 and 11. Multiple factors can influence ...